CONDUCTING SUCCESSFUL MULTICENTER CLINICAL TRIALS IN CEE
Since 2000, the number of clinical trials held in Central and Eastern Europe (CEE) increased by 12% per year, compared with 8% worldwide. Performing clinical trials in CEE has numerous benefits over other parts of the world, such as finding special patient populations, accelerating recruitment with no loss in data quality, and gaining access to a possible future market for new drugs.
Complete the form below to learn more about the advantages of Central and Eastern Europe clinical trials.
INFORMATION REQUEST